Immediate Impact

1 by Nobel laureates 61 standout
Sub-graph 1 of 24

Citing Papers

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Ligand-tethered lipid nanoparticles for targeted RNA delivery to treat liver fibrosis
2023 StandoutNobel
3 intermediate papers

Works of Peter Schiedermaier being referenced

Effect of propranolol and depot lanreotide SR on postprandial and circadian portal haemodynamics in cirrhosis
2003
Hemodynamic effects of the angiotensin II receptor antagonist irbesartan in patients with cirrhosis and portal hypertension
2001
and 2 more

Author Peers

Author Last Decade Papers Cites
Peter Schiedermaier 424 392 214 26 591
Andrew J. Portal 398 356 256 13 598
J Chesta 610 510 242 28 737
Helena Masnou 526 511 211 26 689
Raquel Abecasis 479 464 239 19 609
Patrícia Huelin 472 353 224 26 640
José Milicua 424 361 267 18 609
Ming-Hung Tsai 365 315 223 21 579
Giacomo Zaccherini 410 397 152 40 696
Raymond Sayegh 324 339 188 33 537
Ji-Tseng Fang 316 312 192 20 604

All Works

Loading papers...

Rankless by CCL
2026